Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Updates in Surgery|August 21, 2024
Active thymus in adult with lung cancer: preliminary results from the Adult Thymic ProjectSimona Sobrero, Enrico Patrucco, Francesca Napoli, et al.
FEBS Letters|December 29, 2004
Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP levelGiuseppe Alloatti, Andrea Marcantoni, Renzo Levi, et al.
Critical Care Medicine|December 24, 2005
Lack of phosphoinositide 3-kinase-gamma attenuates ventilator-induced lung injuryVincenzo Lionetti, Alberto Lisi, Enrico Patrucco, et al.
The American Journal of Pathology|December 8, 2004
Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitisEnrico Lupia, Alberto Goffi, Paolo De Giuli, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2007
Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gammaCarlotta Costa, Laura Barberis, Chiara Ambrogio, et al.
Cell|August 6, 2004
PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effectsEnrico Patrucco, Antonella Notte, Laura Barberis, et al.
Molecular Oncology|January 22, 2025
Oncogenic mutant KRAS inhibition through oxidation at cysteine 118Maximilian Kramer-Drauberg, Ettore Petrini, Alessia Mira, et al.
The Journal of Experimental Medicine|April 13, 2005
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3KgammaCarmine Vecchione, Enrico Patrucco, Gennaro Marino, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2025
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRAS<sup>G12D</sup> inhibitor in KRAS LUADFernando C Baltanás, Maximilian Kramer-Drauberg, Rósula García-Navas, et al.
Blood|October 17, 2021
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphomaElif Karaca Atabay, Carmen Mecca, Qi Wang, et al.
Pageof 3